Assets
| Type | Time | Amount | Unit |
|---|
Revenue
| Type | Start date | End date | Amount | Unit |
|---|
XML
See the xml submitted here:
XML: INVALID
Separator
The full data:
<?xml version="1.0" encoding="UTF-8"?>
<!-- Version: 1.1.1264.0 -->
<!-- Document created: 15-04-2024 21:26:21 -->
<!-- Created by: XBRL Wizard, EasyX -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://xbrl.org/2006/xbrldi http://www.xbrl.org/2006/xbrldi-2006.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:entry02-ifrs-dk_2021-12-20="http://xbrl.dcca.dk/ifrs-dk/entry02-ifrs-dk_2021-12-20" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2014-03-05/ifrs-full" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:info="http://xbrl.iasb.org/info" xmlns:ifrs-mc="http://xbrl.ifrs.org/taxonomy/2014-03-05/ifrs-mc" xmlns:rol_ifrs-dk_105.00_2021-12-20="http://xbrl.dcca.dk/role/ifrs-dk/rol_ifrs-dk_105.00_2021-12-20" xmlns:tch="http://xbrl.dcca.dk/tch" xmlns:gen="http://xbrl.org/2008/generic" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:entry="http://entry" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:reference="http://xbrl.org/2008/reference" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:cmn="http://xbrl.dcca.dk/cmn" xmlns:label="http://xbrl.org/2008/label" xmlns:rol_ifrs-dk_110.00_2021-12-20="http://xbrl.dcca.dk/role/ifrs-dk/rol_ifrs-dk_110.00_2021-12-20" xmlns:rol_ifrs-dk_210.00_2021-12-20="http://xbrl.dcca.dk/role/ifrs-dk/rol_ifrs-dk_210.00_2021-12-20" xmlns:rol_ifrs-dk_320.00_2021-12-20="http://xbrl.dcca.dk/role/ifrs-dk/rol_ifrs-dk_320.00_2021-12-20" xmlns:rol_ifrs-dk_330.00_2021-12-20="http://xbrl.dcca.dk/role/ifrs-dk/rol_ifrs-dk_330.00_2021-12-20" xmlns:rol_ifrs-dk_410.00_2021-12-20="http://xbrl.dcca.dk/role/ifrs-dk/rol_ifrs-dk_410.00_2021-12-20" xmlns:rol_ifrs-dk_520.00_2021-12-20="http://xbrl.dcca.dk/role/ifrs-dk/rol_ifrs-dk_520.00_2021-12-20" xmlns:rol_ifrs-dk_610.00_2021-12-20="http://xbrl.dcca.dk/role/ifrs-dk/rol_ifrs-dk_610.00_2021-12-20" xmlns:rol_ifrs-dk_710.00_2021-12-20="http://xbrl.dcca.dk/role/ifrs-dk/rol_ifrs-dk_710.00_2021-12-20" xmlns:rol_ifrs-dk_8NN.NN_2021-12-20="http://xbrl.dcca.dk/role/ifrs-dk/rol_ifrs-dk_8NN.NN_2021-12-20" xmlns:rol_dim="http://xbrl.ifrs.org/role/ifrs/dimensions" xmlns:ifrs-dk="http://xbrl.dcca.dk/ifrs-dk-cor_2021-12-20" xmlns:entry-sob="http://xbrl.dcca.dk/entry-sob" xmlns:sob="http://xbrl.dcca.dk/sob" xmlns:rol_sob_300.00_2021-12-20="http://xbrl.dcca.dk/role/sob/rol_sob_300.00_2021-12-20" xmlns:cmn_rol="http://archprod.service.eogs.dk/taxonomy/20211220/cmn_rol.xsd" xmlns:rol_mrv_2021-12-20="http://xbrl.dcca.dk/role/mrv/rol_mrv_2021-12-20" xmlns:tax="http://xbrl.dcca.dk/tax" xmlns:gsd="http://xbrl.dcca.dk/gsd" xmlns:dst="http://xbrl.dcca.dk/dst" xmlns:ifrs-temp-entry="http://ifrs-temp-entry" xmlns:fsa="http://xbrl.dcca.dk/fsa" xmlns:rol_ps_mc_2014-03-05="http://xbrl.ifrs.org/role/ifrs/rol_ps_mc_2014-03-05" xmlns:mrv="http://xbrl.dcca.dk/mrv" xmlns:esg="http://xbrl.dcca.dk/esg" xmlns:tar="http://xbrl.dcca.dk/tar" xmlns:entry-mrv="http://xbrl.dcca.dk/entry-mrv" xmlns:mrvcsr="http://xbrl.dcca.dk/mrvcsr" xmlns:entry-gsd="http://xbrl.dcca.dk/entry-gsd" xmlns:ca="http://xbrl.org/2008/assertion/consistency" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:variable="http://xbrl.org/2008/variable" xmlns:xfi="http://www.xbrl.org/2008/function/instance" xmlns:cf="http://xbrl.org/2008/filter/concept" xmlns:valm="http://xbrl.org/2010/message/validation" xmlns:ea="http://xbrl.org/2008/assertion/existence" xmlns:validation="http://xbrl.org/2008/validation" xmlns:formula="http://xbrl.org/2008/formula" xmlns:msg="http://xbrl.org/2010/message" xmlns:va="http://xbrl.org/2008/assertion/value" xmlns:rol_gsd_000.00_2021-12-20="http://xbrl.dcca.dk/role/gsd/rol_gsd_000.00_2021-12-20" xmlns:entry-arr="http://xbrl.dcca.dk/entry-arr" xmlns:arr="http://xbrl.dcca.dk/arr" xmlns:rol_arr_1NN.NN_2021-12-20="http://xbrl.dcca.dk/role/arr/rol_arr_1NN.NN_2021-12-20" xmlns:rol_ifrs-dk_510.00_2021-12-20="http://xbrl.dcca.dk/role/ifrs-dk/rol_ifrs-dk_510.00_2021-12-20" xmlns:easy="http://www.easyx.dk/XBRL">
<link:schemaRef xlink:type="simple" xlink:href="http://archprod.service.eogs.dk/taxonomy/extension/orph_20240415/orph_entry_20240415.xsd" />
<xbrli:context id="ctx1">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">32266355</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2023-01-01</xbrli:startDate>
<xbrli:endDate>2023-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="ctx2">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">32266355</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2022-01-01</xbrli:startDate>
<xbrli:endDate>2022-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="ctx3">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">32266355</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2022-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="ctx4">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">32266355</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2023-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="ctx5">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">32266355</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2023-01-01</xbrli:startDate>
<xbrli:endDate>2023-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="ifrs-dk:IdentificationOfComponentOfCashFlowsFromUsedInOperatingActivitiesDimension">
<ifrs-dk:componentOfCashFlowsIdentifier>0</ifrs-dk:componentOfCashFlowsIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx6">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">32266355</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2022-01-01</xbrli:startDate>
<xbrli:endDate>2022-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="ifrs-dk:IdentificationOfComponentOfCashFlowsFromUsedInOperatingActivitiesDimension">
<ifrs-dk:componentOfCashFlowsIdentifier>1</ifrs-dk:componentOfCashFlowsIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx7">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">32266355</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2023-01-01</xbrli:startDate>
<xbrli:endDate>2023-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="ifrs-dk:IdentificationOfComponentOfCashFlowsFromUsedInOperatingActivitiesDimension">
<ifrs-dk:componentOfCashFlowsIdentifier>2</ifrs-dk:componentOfCashFlowsIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx8">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">32266355</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2022-01-01</xbrli:startDate>
<xbrli:endDate>2022-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="ifrs-dk:IdentificationOfComponentOfCashFlowsFromUsedInOperatingActivitiesDimension">
<ifrs-dk:componentOfCashFlowsIdentifier>3</ifrs-dk:componentOfCashFlowsIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx9">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">32266355</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2023-01-01</xbrli:startDate>
<xbrli:endDate>2023-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="ifrs-dk:IdentificationOfComponentOfCashFlowsFromUsedInOperatingActivitiesDimension">
<ifrs-dk:componentOfCashFlowsIdentifier>4</ifrs-dk:componentOfCashFlowsIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx10">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">32266355</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2022-01-01</xbrli:startDate>
<xbrli:endDate>2022-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="ifrs-dk:IdentificationOfComponentOfCashFlowsFromUsedInOperatingActivitiesDimension">
<ifrs-dk:componentOfCashFlowsIdentifier>5</ifrs-dk:componentOfCashFlowsIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx11">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">32266355</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2023-01-01</xbrli:startDate>
<xbrli:endDate>2023-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="ifrs-dk:IdentificationOfComponentOfCashFlowsFromUsedInOperatingActivitiesDimension">
<ifrs-dk:componentOfCashFlowsIdentifier>6</ifrs-dk:componentOfCashFlowsIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx12">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">32266355</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2022-01-01</xbrli:startDate>
<xbrli:endDate>2022-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="ifrs-dk:IdentificationOfComponentOfCashFlowsFromUsedInOperatingActivitiesDimension">
<ifrs-dk:componentOfCashFlowsIdentifier>7</ifrs-dk:componentOfCashFlowsIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx13">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">32266355</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2023-01-01</xbrli:startDate>
<xbrli:endDate>2023-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="ifrs-dk:IdentificationOfComponentOfCashFlowsFromUsedInOperatingActivitiesDimension">
<ifrs-dk:componentOfCashFlowsIdentifier>8</ifrs-dk:componentOfCashFlowsIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx14">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">32266355</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2022-01-01</xbrli:startDate>
<xbrli:endDate>2022-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="ifrs-dk:IdentificationOfComponentOfCashFlowsFromUsedInOperatingActivitiesDimension">
<ifrs-dk:componentOfCashFlowsIdentifier>9</ifrs-dk:componentOfCashFlowsIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx15">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">32266355</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2023-01-01</xbrli:startDate>
<xbrli:endDate>2023-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="ifrs-dk:IdentificationOfComponentOfCashFlowsFromUsedInOperatingActivitiesDimension">
<ifrs-dk:componentOfCashFlowsIdentifier>10</ifrs-dk:componentOfCashFlowsIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx16">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">32266355</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2022-01-01</xbrli:startDate>
<xbrli:endDate>2022-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="ifrs-dk:IdentificationOfComponentOfCashFlowsFromUsedInOperatingActivitiesDimension">
<ifrs-dk:componentOfCashFlowsIdentifier>11</ifrs-dk:componentOfCashFlowsIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx17">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">32266355</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2023-01-01</xbrli:startDate>
<xbrli:endDate>2023-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="ifrs-dk:IdentificationOfComponentOfCashFlowsFromUsedInOperatingActivitiesDimension">
<ifrs-dk:componentOfCashFlowsIdentifier>12</ifrs-dk:componentOfCashFlowsIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx18">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">32266355</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2022-01-01</xbrli:startDate>
<xbrli:endDate>2022-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="ifrs-dk:IdentificationOfComponentOfCashFlowsFromUsedInOperatingActivitiesDimension">
<ifrs-dk:componentOfCashFlowsIdentifier>13</ifrs-dk:componentOfCashFlowsIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx19">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">32266355</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2023-01-01</xbrli:startDate>
<xbrli:endDate>2023-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="ifrs-dk:IdentificationOfComponentOfCashFlowsFromUsedInOperatingActivitiesDimension">
<ifrs-dk:componentOfCashFlowsIdentifier>14</ifrs-dk:componentOfCashFlowsIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx20">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">32266355</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2022-01-01</xbrli:startDate>
<xbrli:endDate>2022-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="ifrs-dk:IdentificationOfComponentOfCashFlowsFromUsedInOperatingActivitiesDimension">
<ifrs-dk:componentOfCashFlowsIdentifier>15</ifrs-dk:componentOfCashFlowsIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx21">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">32266355</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2023-01-01</xbrli:startDate>
<xbrli:endDate>2023-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="ifrs-dk:IdentificationOfComponentOfCashFlowsFromUsedInOperatingActivitiesDimension">
<ifrs-dk:componentOfCashFlowsIdentifier>16</ifrs-dk:componentOfCashFlowsIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx22">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">32266355</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2022-01-01</xbrli:startDate>
<xbrli:endDate>2022-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="ifrs-dk:IdentificationOfComponentOfCashFlowsFromUsedInOperatingActivitiesDimension">
<ifrs-dk:componentOfCashFlowsIdentifier>17</ifrs-dk:componentOfCashFlowsIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx23">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">32266355</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2023-01-01</xbrli:startDate>
<xbrli:endDate>2023-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="ifrs-dk:IdentificationOfComponentOfCashFlowsFromUsedInInvestingActivitiesDimension">
<ifrs-dk:componentOfCashFlowsIdentifier>0</ifrs-dk:componentOfCashFlowsIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx24">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">32266355</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2022-01-01</xbrli:startDate>
<xbrli:endDate>2022-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="ifrs-dk:IdentificationOfComponentOfCashFlowsFromUsedInInvestingActivitiesDimension">
<ifrs-dk:componentOfCashFlowsIdentifier>1</ifrs-dk:componentOfCashFlowsIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx25">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">32266355</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2023-01-01</xbrli:startDate>
<xbrli:endDate>2023-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="ifrs-dk:IdentificationOfComponentOfCashFlowsFromUsedInInvestingActivitiesDimension">
<ifrs-dk:componentOfCashFlowsIdentifier>2</ifrs-dk:componentOfCashFlowsIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx26">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">32266355</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2022-01-01</xbrli:startDate>
<xbrli:endDate>2022-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="ifrs-dk:IdentificationOfComponentOfCashFlowsFromUsedInInvestingActivitiesDimension">
<ifrs-dk:componentOfCashFlowsIdentifier>3</ifrs-dk:componentOfCashFlowsIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx27">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">32266355</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2023-01-01</xbrli:startDate>
<xbrli:endDate>2023-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="ifrs-dk:IdentificationOfComponentOfCashFlowsFromUsedInFinancingActivitiesDimension">
<ifrs-dk:componentOfCashFlowsIdentifier>0</ifrs-dk:componentOfCashFlowsIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx28">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">32266355</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2022-01-01</xbrli:startDate>
<xbrli:endDate>2022-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="ifrs-dk:IdentificationOfComponentOfCashFlowsFromUsedInFinancingActivitiesDimension">
<ifrs-dk:componentOfCashFlowsIdentifier>1</ifrs-dk:componentOfCashFlowsIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx29">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">32266355</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2023-01-01</xbrli:startDate>
<xbrli:endDate>2023-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="ifrs-dk:IdentificationOfComponentOfCashFlowsFromUsedInFinancingActivitiesDimension">
<ifrs-dk:componentOfCashFlowsIdentifier>2</ifrs-dk:componentOfCashFlowsIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx30">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">32266355</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2022-01-01</xbrli:startDate>
<xbrli:endDate>2022-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="ifrs-dk:IdentificationOfComponentOfCashFlowsFromUsedInFinancingActivitiesDimension">
<ifrs-dk:componentOfCashFlowsIdentifier>3</ifrs-dk:componentOfCashFlowsIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx31">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">32266355</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2023-01-01</xbrli:startDate>
<xbrli:endDate>2023-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="ifrs-dk:IdentificationOfComponentOfCashFlowsFromUsedInFinancingActivitiesDimension">
<ifrs-dk:componentOfCashFlowsIdentifier>4</ifrs-dk:componentOfCashFlowsIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx32">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">32266355</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2022-01-01</xbrli:startDate>
<xbrli:endDate>2022-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="ifrs-dk:IdentificationOfComponentOfCashFlowsFromUsedInFinancingActivitiesDimension">
<ifrs-dk:componentOfCashFlowsIdentifier>5</ifrs-dk:componentOfCashFlowsIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx33">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">32266355</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2023-01-01</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="ctx34">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">32266355</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2022-01-01</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="ctx35">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">32266355</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2023-01-01</xbrli:startDate>
<xbrli:endDate>2023-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="cmn:IdentificationOfMemberOfSupervisoryBoardAxis">
<cmn:memberOfBoardIdentifier>0</cmn:memberOfBoardIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx36">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">32266355</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2023-01-01</xbrli:startDate>
<xbrli:endDate>2023-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="cmn:IdentificationOfMemberOfSupervisoryBoardAxis">
<cmn:memberOfBoardIdentifier>1</cmn:memberOfBoardIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx37">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">32266355</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2023-01-01</xbrli:startDate>
<xbrli:endDate>2023-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="cmn:IdentificationOfMemberOfExecutiveBoardAxis">
<cmn:memberOfBoardIdentifier>0</cmn:memberOfBoardIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx38">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">32266355</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2023-01-01</xbrli:startDate>
<xbrli:endDate>2023-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="cmn:IdentificationOfMemberOfExecutiveBoardAxis">
<cmn:memberOfBoardIdentifier>1</cmn:memberOfBoardIdentifier>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:context id="ctx39">
<xbrli:entity>
<xbrli:identifier scheme="http://www.dcca.dk/cvr">32266355</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2023-01-01</xbrli:startDate>
<xbrli:endDate>2023-12-31</xbrli:endDate>
</xbrli:period>
<xbrli:scenario>
<xbrldi:typedMember dimension="cmn:IdentificationOfAuditorDimension">
<cmn:auditorIdentificer>0</cmn:auditorIdentificer>
</xbrldi:typedMember>
</xbrli:scenario>
</xbrli:context>
<xbrli:unit id="vDKK">
<xbrli:measure>iso4217:DKK</xbrli:measure>
</xbrli:unit>
<xbrli:unit id="share">
<xbrli:measure>xbrli:shares</xbrli:measure>
</xbrli:unit>
<gsd:ReportingPeriodStartDate contextRef="ctx1">2023-01-01</gsd:ReportingPeriodStartDate>
<gsd:ReportingPeriodEndDate contextRef="ctx1">2023-12-31</gsd:ReportingPeriodEndDate>
<gsd:NameOfReportingEntity contextRef="ctx1" xml:lang="da">Orphazyme A/S</gsd:NameOfReportingEntity>
<gsd:IdentificationNumberCvrOfReportingEntity contextRef="ctx1">32266355</gsd:IdentificationNumberCvrOfReportingEntity>
<gsd:AddressOfReportingEntityStreetName contextRef="ctx1" xml:lang="da">Herlev, Denmark</gsd:AddressOfReportingEntityStreetName>
<gsd:DateOfGeneralMeeting contextRef="ctx1">2024-04-18</gsd:DateOfGeneralMeeting>
<gsd:NameAndSurnameOfChairmanOfGeneralMeeting contextRef="ctx1" xml:lang="da">Jakob Bendtsen</gsd:NameAndSurnameOfChairmanOfGeneralMeeting>
<mrv:CorporateGovernanceReport contextRef="ctx1" xml:lang="da"><table xmlns="http://www.w3.org/1999/xhtml" style="border-right: 0px; border-top: 0px; border-left: 0px; width: 650px; border-bottom: 0px; border-collapse: collapse" width="100%"><tr><td colspan="5">Corporate Governance</td></tr><tr><td colspan="5">Orphazyme is committed to ensuring transparent and good corporate governance. As a Danish company listed</td></tr><tr><td colspan="5">on Nasdaq Copenhagen, Orphazyme is subject to the Danish Recommendations on Corporate Governance. The</td></tr><tr><td colspan="5">Recommendations on Corporate Governance are best practice guidelines for the management of companies</td></tr><tr><td colspan="5">admitted to trading on a regulated market.</td></tr><tr><td colspan="5">Orphazyme complies with the Recommendations on Corporate Governance where deemed relevant given</td></tr><tr><td colspan="5">Orphazymeâs current situation and focus.</td></tr><tr><td colspan="5">Orphazymeâs corporate governance statement includes Orphazymeâs position on the Recommendation on</td></tr><tr><td colspan="5">Corporate Governance as well as a complete list of the Companyâs comments to recommendations that the</td></tr><tr><td colspan="5">Company opted to deviate from.The corporate governance statement is available under âCorporate</td></tr><tr><td colspan="5">Governanceâ in the Investors &amp; Media section of our website: investors.orphazyme.com/corporate-governance.</td></tr><tr><td colspan="5">Board of Directors</td></tr><tr><td colspan="5">The Board of Directors is responsible for the overall management and strategic direction of Orphazymeâs</td></tr><tr><td colspan="5">business and operations and it supervises the Companyâs activities, management, and organization. The Board</td></tr><tr><td colspan="5">of Directors appoints and dismisses the members of the Executive Management, who are responsible for the</td></tr><tr><td colspan="5">day-to-day management of the Company.</td></tr><tr><td colspan="5">The Board has chosen that the functions of the Audit Committee are exercised by the entire board of directors</td></tr><tr><td colspan="5">with Jakob Have as Chairman of the Audit Committee.</td></tr><tr><td colspan="5">Meetings</td></tr><tr><td colspan="5">The Board of Directors normally holds at least five regular meetings annually, including a strategy review, plus</td></tr><tr><td colspan="5">ad-hoc meetings as required. Extraordinary board meetings are convened by the Chairman when necessary or</td></tr><tr><td colspan="5">when requested by a member of the Board of Directors, a member of the Executive Management, or by the</td></tr><tr><td colspan="5">Companyâs auditor. There was a high frequency of meetings in 2023 due to the change in management,</td></tr><tr><td colspan="5">initiatives to strengthen the capital structure of the Company and US lawsuit. The Board of Directors forms a</td></tr><tr><td colspan="5">quorum when more than half of its members are represented, including the Chairman. Resolutions of the Board</td></tr><tr><td colspan="5">of Directors are passed by a simple majority of the votes present at the meeting. In the event of equal votes,</td></tr><tr><td colspan="5">the Chairman shall have the casting vote.</td></tr><tr><td colspan="5">The members of the Board of Directors elected by the general meeting are elected for a term of one year.</td></tr><tr><td colspan="5">Members of the Board of Directors may be re-elected.</td></tr><tr><td colspan="5">Orphazyme Board of Directors</td></tr><tr><td>Name</td><td>Position</td><td>Independent (1)</td><td>Year of first</td><td>Expiration of</td></tr><tr><td /><td /><td /><td>appointment</td><td>term</td></tr><tr><td>Michael Hove</td><td>Chairman</td><td>Independent</td><td>2023</td><td>2024</td></tr><tr><td>Jakob Have</td><td>Member</td><td>Independent</td><td>2023</td><td>2024</td></tr><tr><td>Jakob Bendtsen</td><td>Member</td><td>Not Independent</td><td>2023</td><td>2024</td></tr><tr><td /><td /><td /><td colspan="2">(1) According to the Danish Recommendations on Corporate Governance at least half of the members of the</td></tr><tr><td colspan="5">Board of Directors should be independent.</td></tr></table></mrv:CorporateGovernanceReport>
<mrv:StatementOfCorporateSocialResponsibility contextRef="ctx1" xml:lang="da"><table xmlns="http://www.w3.org/1999/xhtml" style="border-right: 0px; border-top: 0px; border-left: 0px; width: 650px; border-bottom: 0px; border-collapse: collapse" width="100%"><tr><td colspan="1">Corporate Social Responsibility</td></tr><tr><td colspan="1">This section constitutes the Companyâs statutory reporting according to Section 99a of the Danish Financial</td></tr><tr><td colspan="1">Statements Act.</td></tr><tr><td colspan="1">In May 2022, substantially all Orphazymeâs assets and business activities were sold to Zevra and we now have</td></tr><tr><td colspan="1">limited ongoing operational business activities and employees. Our headquarter is in Copenhagen, and we have</td></tr><tr><td colspan="1">non-operating subsidiaries in the U.S. and Switzerland which are expected to be liquidated in 2024.</td></tr><tr><td colspan="1">In light of such limited business operations, Orphazymeâs Corporate and Social Responsibility (CSR) risks are</td></tr><tr><td colspan="1">considered very limited. Our CSR activities for 2023 were commensurate with the size and limited operations of</td></tr><tr><td colspan="1">the Company, though we continued to strive to uphold our values and responsibilities towards society,</td></tr><tr><td colspan="1">employees, and our stakeholders. For 2024 we will continue, where possible, to fulfill our CSR obligations as</td></tr><tr><td colspan="1">we execute our strategy.</td></tr><tr><td colspan="1">CSR reporting areas</td></tr><tr><td colspan="1">Human Rights</td></tr><tr><td colspan="1">Risk: Very Limited: Orphazyme has limited operations, employees and suppliers.</td></tr><tr><td colspan="1">Actions: Continued to respect internationally declared human rights and did not employ child labor.</td></tr><tr><td colspan="1">Policies in place: Orphazyme acknowledges and supports the maintenance of internationally declared human</td></tr><tr><td colspan="1">rights and bases its work on the UN Universal Declaration of Human Rights and the interpretation that it is the</td></tr><tr><td colspan="1">responsibility of the State to protect, and the companiesâ responsibility to respect, these rights. Orphazyme</td></tr><tr><td colspan="1">interprets human rights to comprise respect for diversity.</td></tr><tr><td colspan="1">⢠Diversity policy.</td></tr><tr><td colspan="1">⢠Whistleblower policy.</td></tr><tr><td colspan="1">Results</td></tr><tr><td colspan="1">⢠No diversity related incidents or human rights violations reported in 2023.</td></tr><tr><td colspan="1">⢠Employee composition: Not meaningful given company structure (One employee as of December 31,</td></tr><tr><td colspan="1">2023; male).</td></tr><tr><td colspan="1">⢠Leadership: Not meaningful given company structure (One employee as of December 31, 2023; male).</td></tr><tr><td colspan="1">⢠The Company has set a target of increasing the representation of women on the Board of Directors to</td></tr><tr><td colspan="1">40% by 2026 in accordance with the guidelines from the Danish Business Authority. As at year end</td></tr><tr><td colspan="1">2023 the Board of Directors was comprised of three members, none of which were women.</td></tr><tr><td colspan="1">FuturePlans</td></tr><tr><td colspan="1">⢠Continue to support and respect internationally declared human rights and will not employ child labor.</td></tr><tr><td colspan="1">Aim to improve Board diversity in the future, subject to expansion of current business operations.</td></tr><tr><td colspan="1">Anti-Corruption &amp; Bribery</td></tr><tr><td colspan="1">Risk: Very Limited: We do not tolerate the use of bribery or corruption to achieve business objectives. Given</td></tr><tr><td colspan="1">that we have limited operations, employees and suppliers our anti-corruption and bribery risk is very limited.</td></tr><tr><td colspan="1">Actions: The Company is committed to maintaining the highest standards of conduct and will not tolerate the</td></tr><tr><td colspan="1">use of bribery or corruption to achieve its business objectives.</td></tr><tr><td colspan="1">⢠Anti-corruption and bribery training conducted when employees start.</td></tr><tr><td colspan="1">⢠Legal &amp; Compliance training refreshers, including anti-corruption and bribery</td></tr><tr><td colspan="1">Policies in place: Our policies on bribery and corruption are clearly set out in our anti-corruption policy and</td></tr><tr><td colspan="1">our employee handbook.</td></tr><tr><td colspan="1">Results: No bribery and corruption violations identified or reported in 2023.</td></tr><tr><td colspan="1">Future Plans: Continue to maintain the highest standards of conduct and not tolerate the use of bribery or</td></tr><tr><td colspan="1">corruption to achieve business objectives.</td></tr><tr><td colspan="1">Environment &amp; Climate</td></tr><tr><td colspan="1">Risk: Very limited: We have a very limited number of employees, minimal physical office presence and use</td></tr><tr><td colspan="1">external suppliers for certain activities such as administration, finance and legal activities which we believe</td></tr><tr><td colspan="1">have a low potential risk for impact on the environment &amp; climate.</td></tr><tr><td colspan="1">Actions: Followed established procedures both during use and at disposal of hazardous substances.</td></tr><tr><td colspan="1">Policies in place: Considering the business of the Company, and its limited operations and employees,</td></tr><tr><td colspan="1">Orphazymeâs general potential impact on the environment and climate and the impact of the climate on</td></tr><tr><td colspan="1">Orphazymeâs business is viewed as minimal. Applicable rules and procedures were followed regarding the use</td></tr><tr><td colspan="1">of hazardous substances (no longer relevant due to closure of our laboratory space early in 2022) and we</td></tr><tr><td colspan="1">continue to endeavor to protect the environment and climate through mindful business practices such as, e.g.</td></tr><tr><td colspan="1">careful use of office materials and energy consumption.</td></tr><tr><td colspan="1">Results</td></tr><tr><td colspan="1">⢠Continued to keep records of all accidents in 2023.</td></tr><tr><td colspan="1">⢠Recorded no records of spill of hazardous substances</td></tr><tr><td colspan="1">⢠Continued to focus on efficient energy use and management of office materials in 2023.</td></tr><tr><td colspan="1">Future Plans: Orphazyme is no longer active in research and development activities and further with only</td></tr><tr><td colspan="1">limited operating activities, employees and suppliers focusing on administration, finance and legal activities,</td></tr><tr><td colspan="1">the general potential impact on the environment and climate and the impact of the environment and climate on</td></tr><tr><td colspan="1">Orphazymeâs business is viewed as minimal. We will continue to endeavor to protect the environment and</td></tr><tr><td colspan="1">climate through mindful business practices such as, e.g. careful use of office materials and energy</td></tr><tr><td colspan="1">consumption.</td></tr><tr><td colspan="1">Social / Employees</td></tr><tr><td colspan="1">Risk: Very Limited: As of December 31, 2023, Orphazyme had only one employee. The company continues to</td></tr><tr><td colspan="1">value diversity in gender, age, ethnicity, nationality, religion, education, sexual orientation, work history,</td></tr><tr><td colspan="1">perspectives, opinions, and skills at all levels of our business however given its limited employees it currently</td></tr><tr><td colspan="1">does not have a diverse workforce. Further, the Companyâs limited operations, such as office space and</td></tr><tr><td colspan="1">support network, could impact the working conditions of remaining employees.</td></tr><tr><td colspan="1">Actions: The health and safety of our employees is of utmost importance and Orphazyme continually works to</td></tr><tr><td colspan="1">ensure that all systems and processes meet strict international standards. Continued to foster an open,</td></tr><tr><td colspan="1">trusting and inclusive workplace committed to freedom from discrimination, harassment, and bullying.</td></tr><tr><td colspan="1">Policies in place: Diversity Policy as well as Health and Safety Policies.</td></tr><tr><td colspan="1">Results: Established a resilient culture centered on trust and collaboration.</td></tr><tr><td colspan="1">Future Plans: As of the date of this annual report, the Company has limited ongoing business activities and</td></tr><tr><td colspan="1">only one employee. Our future social / employee activities will be commensurate with the size and limited</td></tr><tr><td colspan="1">operations of the Company. We will continue to strive to uphold our values and responsibilities and promote a</td></tr><tr><td colspan="1">healthy, diverse and inclusive workplace, as we execute our strategy.</td></tr></table></mrv:StatementOfCorporateSocialResponsibility>
<mrv:StatementOfPolicyForDataEthics contextRef="ctx1" xml:lang="da"><table xmlns="http://www.w3.org/1999/xhtml" style="border-right: 0px; border-top: 0px; border-left: 0px; width: 650px; border-bottom: 0px; border-collapse: collapse" width="100%"><tr><td colspan="1">Data Ethics</td></tr><tr><td colspan="1">We currently do not have a data ethics policy. Given the Company has limited operational business activities, it</td></tr><tr><td colspan="1">is no longer an integrated part of the Companyâs business strategy or activities to process data or use</td></tr><tr><td colspan="1">algorithms for data analysis in connection with clinical trials, etc. However, our practices will be evaluated on</td></tr><tr><td colspan="1">an ongoing basis in order to ensure they align with the statutory requirements set forth in Section 99d of the</td></tr><tr><td colspan="1">Danish Financial Statements Act.</td></tr></table></mrv:StatementOfPolicyForDataEthics>
<mrv:StatementOfTheDiversityPolicies contextRef="ctx1" xml:lang="da"><table xmlns="http://www.w3.org/1999/xhtml" style="border-right: 0px; border-top: 0px; border-left: 0px; width: 650px; border-bottom: 0px; border-collapse: collapse" width="100%"><tr><td colspan="2">Diversity in Management Positions</td></tr><tr><td colspan="2">Given the size of our workforce with only one employee, it is not meaningful to set out diversity figures nor is it</td></tr><tr><td colspan="2">required in accordance with the Danish Companies Act. This is also the case for the information requirements</td></tr><tr><td colspan="2">in section 107 d in the Danish Companies Act.</td></tr><tr><td colspan="2">Due to the evolution of the business, there were only three Board members at the end of 2023, all of which</td></tr><tr><td colspan="2">were men. The company remains committed to promoting a diverse and inclusive workplace and has therefore</td></tr><tr><td colspan="2">set a target of increasing the representation of women on the Board of Directors to 40% by 2026 in accordance</td></tr><tr><td colspan="2">with the guidelines from the Danish Business Authority.</td></tr><tr><td /><td>2023</td></tr><tr><td colspan="2">Board of directors</td></tr><tr><td>Total number of members</td><td>3</td></tr><tr><td>Underrepresented gender in %</td><td>0</td></tr><tr><td>Target figure in % Net result from discontinued operations</td><td>40</td></tr><tr><td>Year of target fulfilment</td><td>2026</td></tr><tr><td colspan="2">Other Management levels</td></tr><tr><td>Total number of members (all male)</td><td>1</td></tr></table></mrv:StatementOfTheDiversityPolicies>
<easy:SellingGeneralAndAdministrative contextRef="ctx1" unitRef="vDKK" decimals="-3">27041000</easy:SellingGeneralAndAdministrative>
<ifrs-full:FinanceIncome contextRef="ctx1" unitRef="vDKK" decimals="-3">993000</ifrs-full:FinanceIncome>
<ifrs-full:ProfitLossBeforeTax contextRef="ctx1" unitRef="vDKK" decimals="-3">-26048000</ifrs-full:ProfitLossBeforeTax>
<ifrs-full:ProfitLossFromContinuingOperations contextRef="ctx1" unitRef="vDKK" decimals="-3">-26048000</ifrs-full:ProfitLossFromContinuingOperations>
<ifrs-full:ProfitLoss contextRef="ctx1" unitRef="vDKK" decimals="-3">-26048000</ifrs-full:ProfitLoss>
<ifrs-full:ComprehensiveIncome contextRef="ctx1" unitRef="vDKK" decimals="-3">-26048000</ifrs-full:ComprehensiveIncome>
<ifrs-full:BasicEarningsLossPerShareFromContinuingOperations contextRef="ctx1" unitRef="share" decimals="0">-738</ifrs-full:BasicEarningsLossPerShareFromContinuingOperations>
<ifrs-full:BasicEarningsLossPerShare contextRef="ctx1" unitRef="share" decimals="0">-738</ifrs-full:BasicEarningsLossPerShare>
<ifrs-full:DilutedEarningsLossPerShare contextRef="ctx1" unitRef="share" decimals="0">-733</ifrs-full:DilutedEarningsLossPerShare>
<ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities contextRef="ctx1" unitRef="vDKK" decimals="-3">5500000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
<ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="ctx1" unitRef="vDKK" decimals="-3">-20021000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
<ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="ctx1" unitRef="vDKK" decimals="-3">-6944000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
<ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="ctx1" unitRef="vDKK" decimals="-3">-685000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
<ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges contextRef="ctx1" unitRef="vDKK" decimals="-3">-27650000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges>
<ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents contextRef="ctx1" unitRef="vDKK" decimals="-3">1000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
<sob:IdentificationOfApprovedAnnualReport contextRef="ctx1" xml:lang="da"><table xmlns="http://www.w3.org/1999/xhtml" style="border-right: 0px; border-top: 0px; border-left: 0px; width: 650px; border-bottom: 0px; border-collapse: collapse" width="100%"><tr><td colspan="1">The Board of Directors and Executive Management have today considered and approved the annual report of</td></tr><tr><td colspan="1">Orphazyme A/S for the financial year January 1-December 31, 2023.</td></tr></table></sob:IdentificationOfApprovedAnnualReport>
<sob:ConfirmationThatAnnualReportIsPresentedInAccordanceWithRequirementsProvidedForByLegislationAnyStandardsAndRequirementsProvidedByArticlesOfAssociationOrByAgreement contextRef="ctx1" xml:lang="da"><table xmlns="http://www.w3.org/1999/xhtml" style="border-right: 0px; border-top: 0px; border-left: 0px; width: 650px; border-bottom: 0px; border-collapse: collapse" width="100%"><tr><td colspan="1">The financial statements have been prepared in accordance with International Financial Reporting Standards</td></tr><tr><td colspan="1">(IFRS) as issued by the International Accounting Standards Board (IASB) and in accordance with IFRS as</td></tr><tr><td colspan="1">endorsed by the EU as well as additional disclosure requirements under the Danish Financial Statements Act.</td></tr><tr><td colspan="1">In our opinion, Managementâs Review provides a fair presentation of the development in the operations and</td></tr><tr><td colspan="1">financial circumstances, the results of the year, and the overall financial position of the Company as well as a</td></tr><tr><td colspan="1">description of the most significant risks and elements of uncertainty facing the Company.</td></tr></table></sob:ConfirmationThatAnnualReportIsPresentedInAccordanceWithRequirementsProvidedForByLegislationAnyStandardsAndRequirementsProvidedByArticlesOfAssociationOrByAgreement>
<sob:ConfirmationThatFinancialStatementGivesTrueAndFairViewOfAssetsLiabilitiesEquityFinancialPositionAndResults contextRef="ctx1" xml:lang="da"><table xmlns="http://www.w3.org/1999/xhtml" style="border-right: 0px; border-top: 0px; border-left: 0px; width: 650px; border-bottom: 0px; border-collapse: collapse" width="100%"><tr><td colspan="1">In our opinion, the financial statements provide a fair presentation of the assets, liabilities, and financial</td></tr><tr><td colspan="1">position and the results of the operations and cash flows for the financial year. In our opinion, the Annual</td></tr><tr><td colspan="1">Report of Ambu A/S for the financial year January 1âDecember 31, 2023 identified as OZ-2023-12-31-en.zip</td></tr><tr><td colspan="1">has been prepared, in all material respects, in compliance with the ESEF Regulation.</td></tr></table></sob:ConfirmationThatFinancialStatementGivesTrueAndFairViewOfAssetsLiabilitiesEquityFinancialPositionAndResults>
<sob:RecommendationForApprovalOfAnnualReportByGeneralMeeting contextRef="ctx1" xml:lang="da"><table xmlns="http://www.w3.org/1999/xhtml" style="border-right: 0px; border-top: 0px; border-left: 0px; width: 650px; border-bottom: 0px; border-collapse: collapse" width="100%"><tr><td colspan="1">We recommend that the annual report be adopted at the Annual General Meeting scheduled to be held on April</td></tr><tr><td colspan="1">18, 2024.</td></tr></table></sob:RecommendationForApprovalOfAnnualReportByGeneralMeeting>
<sob:PlaceOfSignatureOfStatement contextRef="ctx1" xml:lang="da">Copenhagen</sob:PlaceOfSignatureOfStatement>
<sob:DateOfApprovalOfAnnualReport contextRef="ctx1">2024-03-27</sob:DateOfApprovalOfAnnualReport>
<arr:IndependentAuditorsReportsAudit contextRef="ctx1" xml:lang="da"><table xmlns="http://www.w3.org/1999/xhtml" style="border-right: 0px; border-top: 0px; border-left: 0px; width: 650px; border-bottom: 0px; border-collapse: collapse" width="100%"><tr><td colspan="1">Independent Auditorsâ Report</td></tr></table></arr:IndependentAuditorsReportsAudit>
<arr:AddresseeOfAuditorsReportOnAuditedFinancialStatements contextRef="ctx1" xml:lang="da"><table xmlns="http://www.w3.org/1999/xhtml" style="border-right: 0px; border-top: 0px; border-left: 0px; width: 650px; border-bottom: 0px; border-collapse: collapse" width="100%"><tr><td colspan="1">To the shareholders of Orphazyme A/S</td></tr><tr><td colspan="1">Report on the audit of the Company's Financial Statements</td></tr></table></arr:AddresseeOfAuditorsReportOnAuditedFinancialStatements>
<arr:OpinionOnAuditedFinancialStatements contextRef="ctx1" xml:lang="da"><table xmlns="http://www.w3.org/1999/xhtml" style="border-right: 0px; border-top: 0px; border-left: 0px; width: 650px; border-bottom: 0px; border-collapse: collapse" width="100%"><tr><td colspan="1">Opinion</td></tr><tr><td colspan="1">In our opinion, the Companyâs financial statements give a true and fair view of the Company's assets, liabilities</td></tr><tr><td colspan="1">and financial position at 31 December 2023 and of the results of the Company's operations and cash flows for</td></tr><tr><td colspan="1">the financial year 1 January â 31 December 2023 in accordance with the IFRS Accounting Standards as</td></tr><tr><td colspan="1">adopted by the EU and additional requirements in the Danish Financial Statements Act.</td></tr><tr><td colspan="1">Our opinion is consistent with our long-form audit report to the Board of Directors and the Audit Committee.</td></tr><tr><td colspan="1">Audited financial statements</td></tr><tr><td colspan="1">Orphazyme A/Sâ financial statements for the financial year 1 January â 31 December 2023 comprise the</td></tr><tr><td colspan="1">income statement, statement of comprehensive income, balance sheet, statement of changes in equity,</td></tr><tr><td colspan="1">statement of cash flows and notes, including summary of material accounting policy information. The financial</td></tr><tr><td colspan="1">statements are prepared in accordance with the IFRS Accounting Standards as adopted by the EU and</td></tr><tr><td colspan="1">additional requirements in the Danish Financial Statements Act.</td></tr></table></arr:OpinionOnAuditedFinancialStatements>
<arr:DescriptionOfQualificationsOfAuditedFinancialStatements contextRef="ctx1" xml:lang="da"><table xmlns="http://www.w3.org/1999/xhtml" style="border-right: 0px; border-top: 0px; border-left: 0px; width: 650px; border-bottom: 0px; border-collapse: collapse" width="100%"><tr><td colspan="1">Basis for opinion</td></tr><tr><td colspan="1">We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional</td></tr><tr><td colspan="1">requirements applicable in Denmark.</td></tr><tr><td colspan="1">Our responsibilities under those standards and requirements are further described in the "Auditor's</td></tr><tr><td colspan="1">responsibilities for the audit of the financial statements" section of our report.</td></tr><tr><td colspan="1">We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our</td></tr><tr><td colspan="1">opinion.</td></tr><tr><td colspan="1">Independence</td></tr><tr><td colspan="1">We are independent of the Company in accordance with the International Ethics Standards Board for</td></tr><tr><td colspan="1">Accountants' International Code of Ethics for Professional Accountants (IESBA Code) and the additional ethical</td></tr><tr><td colspan="1">requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with</td></tr><tr><td colspan="1">these requirements and the IESBA Code.</td></tr><tr><td colspan="1">We declare, to the best of our knowledge and belief, that we have not provided any prohibited non-audit</td></tr><tr><td colspan="1">services, as referred to in Article 5(1) of the Regulation (EU) 537/2014 and that we remained independent in</td></tr><tr><td colspan="1">conducting the audit.</td></tr><tr><td colspan="1">We were appointed auditors of Orphazyme A/S for the first time on November 2, 2023 for the financial year</td></tr><tr><td colspan="1">2023</td></tr></table></arr:DescriptionOfQualificationsOfAuditedFinancialStatements>
<arr:KeyAuditMattersAudit contextRef="ctx1" xml:lang="da"><table xmlns="http://www.w3.org/1999/xhtml" style="border-right: 0px; border-top: 0px; border-left: 0px; width: 650px; border-bottom: 0px; border-collapse: collapse" width="100%"><tr><td colspan="1">Key audit matters</td></tr><tr><td colspan="1">Key audit matters are those matters that, in our professional judgement, were of most significance in our audit</td></tr><tr><td colspan="1">of the financial statements for the 2023 financial year. These matters were addressed in the context of our</td></tr><tr><td colspan="1">audit of the financial statements as a whole, and in the forming of our opinion thereon. We do not provide a</td></tr><tr><td colspan="1">separate opinion on these matters.</td></tr></table><br><table xmlns="http://www.w3.org/1999/xhtml" style="border-right: 0px; border-top: 0px; border-left: 0px; width: 650px; border-bottom: 0px; border-collapse: collapse" width="100%"><tr><td>Key audit matters</td><td>How our audit addressed the key audit matter</td></tr><tr><td colspan="2">Accounting for Settlement of U.S. Lawsuit</td></tr><tr><td>The US class action lawsuit has been closed in</td><td>For the purpose of our audit, the procedures we</td></tr><tr><td>early February 2024 and the settlement amount</td><td>carried out included the following</td></tr><tr><td colspan="2">was USD 2,5 million of which USD 0,5 million was</td></tr><tr><td>covered by insurance leaving a net amount of</td><td>⢠Inquired of management and evaluated their</td></tr><tr><td>USD 2 million which was paid in November 2023.</td><td>assessment of the recognition of expenses in</td></tr><tr><td>Refer to note 2.3 and page 4 of the financial</td><td>2023 when the decision was made by the</td></tr><tr><td>statements for more details.</td><td>court.</td></tr><tr><td /><td>⢠Obtained payment notification from</td></tr><tr><td /><td>management to check to whom the payment</td></tr><tr><td /><td>has been made and the amount is correct per</td></tr><tr><td /><td>the written settlement document. We noted</td></tr><tr><td /><td>that the amount had been transferred to an</td></tr><tr><td /><td>escrow account named after the plaintiffs in</td></tr><tr><td /><td>November 2023.</td></tr><tr><td /><td>⢠Inquired of predecessor auditors to obtain the</td></tr><tr><td /><td>background of the issue as well as evaluation</td></tr><tr><td /><td>of the accounting treatment and disclosure</td></tr><tr><td /><td>thereof in the financial statements.</td></tr><tr><td /><td>⢠Checked if the transaction is classified correctly</td></tr><tr><td /><td>and presented appropriately in the financial</td></tr><tr><td /><td>statements.</td></tr><tr><td /><td>⢠Performed checks of after the year-end bank</td></tr><tr><td /><td>payments to ensure all expenses related to this</td></tr><tr><td /><td>settlement had been accrued for in the correct</td></tr><tr><td /><td>accounting period.</td></tr></table></arr:KeyAuditMattersAudit>
<arr:StatementOnManagementsReviewAuditorsReportOnAuditedFinancialStatements contextRef="ctx1" xml:lang="da"><table xmlns="http://www.w3.org/1999/xhtml" style="border-right: 0px; border-top: 0px; border-left: 0px; width: 650px; border-bottom: 0px; border-collapse: collapse" width="100%"><tr><td colspan="1">Statement on the Managementâs review</td></tr><tr><td colspan="1">Management is responsible for the Management's review.</td></tr><tr><td colspan="1">Our opinion on the financial statements does not cover the Management's review, and we do not express any</td></tr><tr><td colspan="1">form of assurance conclusion thereon.</td></tr><tr><td colspan="1">In connection with our audit of the financial statements, our responsibility is to read the Management's review</td></tr><tr><td colspan="1">and, in doing so, consider whether the Management's review is materially inconsistent with the financial</td></tr><tr><td colspan="1">statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated.</td></tr><tr><td colspan="1">Moreover, it is our responsibility to consider whether the Management's review provides the information</td></tr><tr><td colspan="1">required by relevant law and regulations.</td></tr><tr><td colspan="1">Based on the work we have performed, we conclude that the Management's review is in accordance with the</td></tr><tr><td colspan="1">financial statements and has been prepared in accordance with relevant law and regulations. We did not</td></tr><tr><td colspan="1">identify any material misstatement of the Management's review.</td></tr><tr><td colspan="1">Management's responsibility for the financial statements</td></tr><tr><td colspan="1">Management is responsible for the preparation of financial statements that give a true and fair view in</td></tr><tr><td colspan="1">accordance with the IFRS Accounting Standards as adopted by the EU and additional requirements in the</td></tr><tr><td colspan="1">Danish Financial Statements Act and for such internal control that Management determines is necessary to</td></tr><tr><td colspan="1">enable the preparation of financial statements that are free from material misstatement, whether due to fraud</td></tr><tr><td colspan="1">or error.</td></tr><tr><td colspan="1">In preparing the financial statements, Management is responsible for assessing the Company's ability to</td></tr><tr><td colspan="1">continue as a going concern, disclosing, as applicable, matters related to going concern and using the going</td></tr><tr><td colspan="1">concern basis of accounting unless Management either intends to liquidate the Company or to cease</td></tr><tr><td colspan="1">operations, or has no realistic alternative but to do so.</td></tr></table></arr:StatementOnManagementsReviewAuditorsReportOnAuditedFinancialStatements>
<arr:StatementOfAuditorsResponsibilityForAuditAndAuditPerformed contextRef="ctx1" xml:lang="da"><table xmlns="http://www.w3.org/1999/xhtml" style="border-right: 0px; border-top: 0px; border-left: 0px; width: 650px; border-bottom: 0px; border-collapse: collapse" width="100%"><tr><td colspan="1">Auditor's responsibilities for the audit of the financial statements</td></tr><tr><td colspan="1">Our objectives are to obtain reasonable assurance as to whether the financial statements as a whole are free</td></tr><tr><td colspan="1">from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our</td></tr><tr><td colspan="1">opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in</td></tr><tr><td colspan="1">accordance with ISAs and the additional requirements applicable in Denmark will always detect a material</td></tr><tr><td colspan="1">misstatement when it exists. Misstatements may arise from fraud or error and are considered material if,</td></tr><tr><td colspan="1">individually or in the aggregate, they could reasonably be expected to influence the economic decisions of</td></tr><tr><td colspan="1">users taken on the basis of these financial statements.</td></tr><tr><td colspan="1">As part of an audit conducted in accordance with ISAs and the additional requirements applicable in Denmark,</td></tr><tr><td colspan="1">we exercise professional judgement and maintain professional scepticism throughout the audit. We also</td></tr><tr><td colspan="1">⢠identify and assess the risks of material misstatement of the financial statements, whether due to</td></tr><tr><td colspan="1">fraud or error, design and perform audit procedures responsive to those risks, and obtain audit</td></tr><tr><td colspan="1">evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting</td></tr><tr><td colspan="1">a material misstatement resulting from fraud is higher than for one resulting from error as fraud may</td></tr><tr><td colspan="1">involve collusion, forgery, intentional omissions, misrepresentations or the override of internal control.</td></tr><tr><td colspan="1">⢠obtain an understanding of internal control relevant to the audit in order to design audit procedures</td></tr><tr><td colspan="1">that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the</td></tr><tr><td colspan="1">effectiveness of the Company's internal control.</td></tr><tr><td colspan="1">⢠evaluate the appropriateness of accounting policies used and the reasonableness of accounting</td></tr><tr><td colspan="1">estimates and related disclosures made by Management.</td></tr><tr><td colspan="1">⢠conclude on the appropriateness of Management's use of the going concern basis of accounting in</td></tr><tr><td colspan="1">preparing the financial statements and, based on the audit evidence obtained, whether a material</td></tr><tr><td colspan="1">uncertainty exists related to events or conditions that may cast significant doubt on the Company's</td></tr><tr><td colspan="1">ability to continue as a going concern. If we conclude that a material uncertainty exists, we are</td></tr><tr><td colspan="1">required to draw attention in our auditor's report to the related disclosures in the financial statements</td></tr><tr><td colspan="1">or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit</td></tr><tr><td colspan="1">evidence obtained up to the date of our auditor's report. However, future events or conditions may</td></tr><tr><td colspan="1">cause the Company to cease to continue as a going concern.</td></tr><tr><td colspan="1">⢠evaluate the overall presentation, structure and contents of the financial statements, including the</td></tr><tr><td colspan="1">disclosures, and whether the financial statements represent the underlying transactions and events in</td></tr><tr><td colspan="1">a manner that gives a true and fair view.</td></tr><tr><td colspan="1">⢠obtain sufficient appropriate audit evidence regarding the financial information of the entities or</td></tr><tr><td colspan="1">business activities within the Company to express an opinion on the financial statements. We are</td></tr><tr><td colspan="1">responsible for the direction, supervision and performance of the audit. We remain solely responsible</td></tr><tr><td colspan="1">for our audit opinion.</td></tr><tr><td colspan="1">We communicate with those charged with governance regarding, among other matters, the planned scope and</td></tr><tr><td colspan="1">timing of the audit and significant audit findings, including any significant deficiencies in internal control that</td></tr><tr><td colspan="1">we identify during our audit.</td></tr><tr><td colspan="1">We also provide those charged with governance with a statement that we have complied with relevant ethical</td></tr><tr><td colspan="1">requirements regarding independence, and to communicate with them all relationships and other matters that</td></tr><tr><td colspan="1">may reasonably be thought to bear on our independence, and where applicable, actions taken to eliminate</td></tr><tr><td colspan="1">threats or safeguards applied.</td></tr><tr><td colspan="1">From the matters communicated to those charged with governance, we determine those matters that were of</td></tr><tr><td colspan="1">most significance in the audit of the financial statements of the current period and therefore the key audit</td></tr><tr><td colspan="1">matters. We describe these matters in our auditor's report unless law or regulation precludes public disclosure</td></tr><tr><td colspan="1">about the matter or when, in extremely rare circumstances, we determined that a matter should not be</td></tr><tr><td colspan="1">communicated in our report because the adverse consequences of doing so would reasonably be expected to</td></tr><tr><td colspan="1">outweigh the public interest benefits of such communication.</td></tr><tr><td colspan="1">Report on compliance with the ESEF Regulation</td></tr><tr><td colspan="1">As part of our audit of the Financial Statements of Orphazyme A/S we performed procedures to express an</td></tr><tr><td colspan="1">opinion on whether the annual report of Orphazyme A/S for the financial year 1 January â 31 December 2023</td></tr><tr><td colspan="1">with the file name OZ-2023-12-31-en.zip is prepared, in all material respects, in compliance with the</td></tr><tr><td colspan="1">Commission Delegated Regulation (EU) 2019/815 on the European Single Electronic Format (ESEF Regulation)</td></tr><tr><td colspan="1">which includes requirements related to the preparation of the annual report in XHTML format of the Financial</td></tr><tr><td colspan="1">Statements.</td></tr><tr><td colspan="1">Management is responsible for preparing an annual report that complies with the ESEF Regulation. This</td></tr><tr><td colspan="1">responsibility includes</td></tr><tr><td colspan="1">⢠The preparing of the annual report in XHTML format; and</td></tr><tr><td colspan="1">⢠For such internal control as Management determines necessary to enable the preparation of an annual</td></tr><tr><td colspan="1">report that is compliant with the ESEF Regulation.</td></tr><tr><td colspan="1">Our responsibility is to obtain reasonable assurance on whether the annual report is prepared, in all material</td></tr><tr><td colspan="1">respects, in compliance with the ESEF Regulation based on the evidence we have obtained, and to issue a</td></tr><tr><td colspan="1">report that includes our opinion. The nature, timing and extent of procedures selected depend on the auditorâs</td></tr><tr><td colspan="1">judgement, including the assessment of the risks of material departures from the requirements set out in the</td></tr><tr><td colspan="1">ESEF Regulation, whether due to fraud or error. The procedures include</td></tr><tr><td colspan="1">⢠Testing whether the annual report is prepared in XHTML format;</td></tr><tr><td colspan="1">In our opinion, the annual report of Orphazyme A/S for the financial year 1 January â 31 December 2023 with</td></tr><tr><td colspan="1">the file name OZ-2023-12-31-en.zip is prepared, in all material respects, in compliance with the ESEF</td></tr><tr><td colspan="1">Regulation.</td></tr></table></arr:StatementOfAuditorsResponsibilityForAuditAndAuditPerformed>
<arr:SignatureOfAuditorsPlace contextRef="ctx1" xml:lang="da">Copenhagen</arr:SignatureOfAuditorsPlace>
<arr:SignatureOfAuditorsDate contextRef="ctx1">2024-03-27</arr:SignatureOfAuditorsDate>
<gsd:InformationOnTypeOfSubmittedReport contextRef="ctx1">Ã
rsrapport</gsd:InformationOnTypeOfSubmittedReport>
<gsd:IdentificationNumberCvrOfSubmittingEnterprise contextRef="ctx1">32266355</gsd:IdentificationNumberCvrOfSubmittingEnterprise>
<gsd:NameOfSubmittingEnterprise contextRef="ctx1" xml:lang="da">Ophazyme A/S</gsd:NameOfSubmittingEnterprise>
<gsd:AddressOfSubmittingEnterpriseStreetAndNumber contextRef="ctx1" xml:lang="da">Lyskær 8A</gsd:AddressOfSubmittingEnterpriseStreetAndNumber>
<gsd:AddressOfSubmittingEnterprisePostcodeAndTown contextRef="ctx1" xml:lang="da">2730 Herlev</gsd:AddressOfSubmittingEnterprisePostcodeAndTown>
<gsd:ToolForPreparingTheXBRLInstanceDocument contextRef="ctx1" xml:lang="da">xWizard version 1.1.1264.0, by EasyX Aps. www.easyx.eu</gsd:ToolForPreparingTheXBRLInstanceDocument>
<gsd:PrecedingReportingPeriodStartDate contextRef="ctx1">2022-01-01</gsd:PrecedingReportingPeriodStartDate>
<gsd:PredingReportingPeriodEndDate contextRef="ctx1">2022-12-31</gsd:PredingReportingPeriodEndDate>
<sob:StatementByExecutiveAndSupervisoryBoards contextRef="ctx1" xml:lang="da">Ledelsespåtegning</sob:StatementByExecutiveAndSupervisoryBoards>
<cmn:TypeOfAuditorAssistance contextRef="ctx1">Revisionspåtegning</cmn:TypeOfAuditorAssistance>
<arr:TypeOfBasisForModifiedOpinionOnAuditedFinancialStatements contextRef="ctx1">Grundlag for konklusion</arr:TypeOfBasisForModifiedOpinionOnAuditedFinancialStatements>
<arr:TypeOfModifiedOpinionOnAuditedFinancialStatements contextRef="ctx1">Konklusion</arr:TypeOfModifiedOpinionOnAuditedFinancialStatements>
<easy:SellingGeneralAndAdministrative contextRef="ctx2" unitRef="vDKK" decimals="-3">41241000</easy:SellingGeneralAndAdministrative>
<ifrs-full:FinanceIncome contextRef="ctx2" unitRef="vDKK" decimals="-3">185000</ifrs-full:FinanceIncome>
<ifrs-full:ProfitLossBeforeTax contextRef="ctx2" unitRef="vDKK" decimals="-3">-41056000</ifrs-full:ProfitLossBeforeTax>
<ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="ctx2" unitRef="vDKK" decimals="-3">-2750000</ifrs-full:IncomeTaxExpenseContinuingOperations>
<ifrs-full:ProfitLossFromContinuingOperations contextRef="ctx2" unitRef="vDKK" decimals="-3">-38306000</ifrs-full:ProfitLossFromContinuingOperations>
<ifrs-full:ProfitLossFromDiscontinuedOperations contextRef="ctx2" unitRef="vDKK" decimals="-3">73378000</ifrs-full:ProfitLossFromDiscontinuedOperations>
<ifrs-full:ProfitLoss contextRef="ctx2" unitRef="vDKK" decimals="-3">35072000</ifrs-full:ProfitLoss>
<ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation contextRef="ctx2" unitRef="vDKK" decimals="-3">-141000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
<ifrs-full:OtherComprehensiveIncome contextRef="ctx2" unitRef="vDKK" decimals="-3">-141000</ifrs-full:OtherComprehensiveIncome>
<ifrs-full:ComprehensiveIncome contextRef="ctx2" unitRef="vDKK" decimals="-3">34931000</ifrs-full:ComprehensiveIncome>
<ifrs-full:BasicEarningsLossPerShareFromContinuingOperations contextRef="ctx2" unitRef="share" decimals="0">-1086</ifrs-full:BasicEarningsLossPerShareFromContinuingOperations>
<ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations contextRef="ctx2" unitRef="share" decimals="0">2081</ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations>
<ifrs-full:BasicEarningsLossPerShare contextRef="ctx2" unitRef="share" decimals="0">995</ifrs-full:BasicEarningsLossPerShare>
<ifrs-full:DilutedEarningsLossPerShare contextRef="ctx2" unitRef="share" decimals="0">995</ifrs-full:DilutedEarningsLossPerShare>
<ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense contextRef="ctx2" unitRef="vDKK" decimals="-3">782000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
<ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities contextRef="ctx2" unitRef="vDKK" decimals="-3">5500000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
<ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="ctx2" unitRef="vDKK" decimals="-3">-117945000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
<ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="ctx2" unitRef="vDKK" decimals="-3">1460000</ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
<ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="ctx2" unitRef="vDKK" decimals="-3">90347000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
<ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities contextRef="ctx2" unitRef="vDKK" decimals="-3">-39155000</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
<ifrs-full:PaymentsOfFinanceLeaseLiabilitiesClassifiedAsFinancingActivities contextRef="ctx2" unitRef="vDKK" decimals="-3">-1233000</ifrs-full:PaymentsOfFinanceLeaseLiabilitiesClassifiedAsFinancingActivities>
<ifrs-full:ProceedsFromIssuingShares contextRef="ctx2" unitRef="vDKK" decimals="-3">5451000</ifrs-full:ProceedsFromIssuingShares>
<ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="ctx2" unitRef="vDKK" decimals="-3">-35078000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
<ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges contextRef="ctx2" unitRef="vDKK" decimals="-3">-47298000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges>
<ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents contextRef="ctx2" unitRef="vDKK" decimals="-3">523000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
<ifrs-full:CurrentTaxAssetsCurrent contextRef="ctx3" unitRef="vDKK" decimals="-3">5500000</ifrs-full:CurrentTaxAssetsCurrent>
<ifrs-dk:ReceivablesFromSalesAndServices contextRef="ctx3" unitRef="vDKK" decimals="-3">4103000</ifrs-dk:ReceivablesFromSalesAndServices>
<easy:PrepaymentsAndOtherReceivablesCurrent contextRef="ctx3" unitRef="vDKK" decimals="-3">8305000</easy:PrepaymentsAndOtherReceivablesCurrent>
<ifrs-full:Cash contextRef="ctx3" unitRef="vDKK" decimals="-3">38918000</ifrs-full:Cash>
<ifrs-full:CurrentAssets contextRef="ctx3" unitRef="vDKK" decimals="-3">56826000</ifrs-full:CurrentAssets>
<ifrs-full:Assets contextRef="ctx3" unitRef="vDKK" decimals="-3">56826000</ifrs-full:Assets>
<ifrs-full:IssuedCapital contextRef="ctx3" unitRef="vDKK" decimals="-3">35312000</ifrs-full:IssuedCapital>
<ifrs-full:SharePremium contextRef="ctx3" unitRef="vDKK" decimals="-3">2087437000</ifrs-full:SharePremium>
<ifrs-full:OtherReserves contextRef="ctx3" unitRef="vDKK" decimals="-3">-303000</ifrs-full:OtherReserves>
<ifrs-full:RetainedEarnings contextRef="ctx3" unitRef="vDKK" decimals="-3">-2081472000</ifrs-full:RetainedEarnings>
<ifrs-full:Equity contextRef="ctx3" unitRef="vDKK" decimals="-3">40974000</ifrs-full:Equity>
<ifrs-full:OtherNoncurrentLiabilities contextRef="ctx3" unitRef="vDKK" decimals="-3">98000</ifrs-full:OtherNoncurrentLiabilities>
<ifrs-full:NoncurrentLiabilities contextRef="ctx3" unitRef="vDKK" decimals="-3">98000</ifrs-full:NoncurrentLiabilities>
<ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers contextRef="ctx3" unitRef="vDKK" decimals="-3">9206000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
<easy:DiscountAndRebateLiabilities contextRef="ctx3" unitRef="vDKK" decimals="-3">4457000</easy:DiscountAndRebateLiabilities>
<ifrs-full:OtherCurrentPayables contextRef="ctx3" unitRef="vDKK" decimals="-3">2090000</ifrs-full:OtherCurrentPayables>
<ifrs-full:CurrentLiabilities contextRef="ctx3" unitRef="vDKK" decimals="-3">15753000</ifrs-full:CurrentLiabilities>
<ifrs-full:EquityAndLiabilities contextRef="ctx3" unitRef="vDKK" decimals="-3">56826000</ifrs-full:EquityAndLiabilities>
<ifrs-full:CashAndCashEquivalents contextRef="ctx3" unitRef="vDKK" decimals="-3">38918000</ifrs-full:CashAndCashEquivalents>
<easy:PrepaymentsAndOtherReceivablesCurrent contextRef="ctx4" unitRef="vDKK" decimals="-3">1099000</easy:PrepaymentsAndOtherReceivablesCurrent>
<ifrs-dk:CurrentSecurities contextRef="ctx4" unitRef="vDKK" decimals="-3">6944000</ifrs-dk:CurrentSecurities>
<ifrs-full:Cash contextRef="ctx4" unitRef="vDKK" decimals="-3">11269000</ifrs-full:Cash>
<ifrs-full:CurrentAssets contextRef="ctx4" unitRef="vDKK" decimals="-3">19312000</ifrs-full:CurrentAssets>
<ifrs-full:Assets contextRef="ctx4" unitRef="vDKK" decimals="-3">19312000</ifrs-full:Assets>
<ifrs-full:IssuedCapital contextRef="ctx4" unitRef="vDKK" decimals="-3">12283000</ifrs-full:IssuedCapital>
<ifrs-full:RetainedEarnings contextRef="ctx4" unitRef="vDKK" decimals="-3">1959000</ifrs-full:RetainedEarnings>
<ifrs-full:Equity contextRef="ctx4" unitRef="vDKK" decimals="-3">14242000</ifrs-full:Equity>
<ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers contextRef="ctx4" unitRef="vDKK" decimals="-3">5070000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
<ifrs-full:CurrentLiabilities contextRef="ctx4" unitRef="vDKK" decimals="-3">5070000</ifrs-full:CurrentLiabilities>
<ifrs-full:EquityAndLiabilities contextRef="ctx4" unitRef="vDKK" decimals="-3">19312000</ifrs-full:EquityAndLiabilities>
<ifrs-full:CashAndCashEquivalents contextRef="ctx4" unitRef="vDKK" decimals="-3">11269000</ifrs-full:CashAndCashEquivalents>
<ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx5" xml:lang="da">Operating result from continuing operations</ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx5" unitRef="vDKK" decimals="-3">-27041000</ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx6" xml:lang="da">Operating result from continuing operations</ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx6" unitRef="vDKK" decimals="-3">-41241000</ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx7" xml:lang="da">Operating result from discontinuing operations</ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx8" xml:lang="da">Operating result from discontinuing operations</ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx8" unitRef="vDKK" decimals="-3">-67278000</ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx9" xml:lang="da">Equity-settled share-based compensation expense</ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx10" xml:lang="da">Equity-settled share-based compensation expense</ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx10" unitRef="vDKK" decimals="-3">1773000</ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx11" xml:lang="da">Change in prepayments, deposits, and other receivables</ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx11" unitRef="vDKK" decimals="-3">7125000</ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx12" xml:lang="da">Change in prepayments, deposits, and other receivables</ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx12" unitRef="vDKK" decimals="-3">41393000</ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx13" xml:lang="da">Change in trade payables, accruals, and other liabilities</ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx13" unitRef="vDKK" decimals="-3">-10124000</ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx14" xml:lang="da">Change in trade payables, accruals, and other liabilities</ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx14" unitRef="vDKK" decimals="-3">-37889000</ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx15" xml:lang="da">Change in intercompany receivables</ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx15" unitRef="vDKK" decimals="-3">4183000</ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx16" xml:lang="da">Change in intercompany receivables</ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx16" unitRef="vDKK" decimals="-3">1117000</ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx17" xml:lang="da">Change in intercompany payables</ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx17" unitRef="vDKK" decimals="-3">-657000</ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx18" xml:lang="da">Change in intercompany payables</ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx18" unitRef="vDKK" decimals="-3">-7794000</ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx19" xml:lang="da">Interest received</ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx19" unitRef="vDKK" decimals="-3">993000</ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx20" xml:lang="da">Interest received</ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx20" unitRef="vDKK" decimals="-3">185000</ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx21" xml:lang="da">Interest paid</ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx22" xml:lang="da">Interest paid</ifrs-dk:NameOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities contextRef="ctx22" unitRef="vDKK" decimals="-3">-1064000</ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInOperatingActivities>
<ifrs-dk:NameOfComponentOfCashFlowsFromUsedInInvestingActivities contextRef="ctx23" xml:lang="da">Proceeds from sale of activity</ifrs-dk:NameOfComponentOfCashFlowsFromUsedInInvestingActivities>
<ifrs-dk:NameOfComponentOfCashFlowsFromUsedInInvestingActivities contextRef="ctx24" xml:lang="da">Proceeds from sale of activity</ifrs-dk:NameOfComponentOfCashFlowsFromUsedInInvestingActivities>
<ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInInvestingActivities contextRef="ctx24" unitRef="vDKK" decimals="-3">88887000</ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInInvestingActivities>
<ifrs-dk:NameOfComponentOfCashFlowsFromUsedInInvestingActivities contextRef="ctx25" xml:lang="da">Purchase of securities</ifrs-dk:NameOfComponentOfCashFlowsFromUsedInInvestingActivities>
<ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInInvestingActivities contextRef="ctx25" unitRef="vDKK" decimals="-3">-6944000</ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInInvestingActivities>
<ifrs-dk:NameOfComponentOfCashFlowsFromUsedInInvestingActivities contextRef="ctx26" xml:lang="da">Purchase of securities</ifrs-dk:NameOfComponentOfCashFlowsFromUsedInInvestingActivities>
<ifrs-dk:NameOfComponentOfCashFlowsFromUsedInFinancingActivities contextRef="ctx27" xml:lang="da">Purchase of shares in connection with reverse stock split</ifrs-dk:NameOfComponentOfCashFlowsFromUsedInFinancingActivities>
<ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInFinancingActivities contextRef="ctx27" unitRef="vDKK" decimals="-3">-3020000</ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInFinancingActivities>
<ifrs-dk:NameOfComponentOfCashFlowsFromUsedInFinancingActivities contextRef="ctx28" xml:lang="da">Purchase of shares in connection with reverse stock split</ifrs-dk:NameOfComponentOfCashFlowsFromUsedInFinancingActivities>
<ifrs-dk:NameOfComponentOfCashFlowsFromUsedInFinancingActivities contextRef="ctx29" xml:lang="da">Sale of shares</ifrs-dk:NameOfComponentOfCashFlowsFromUsedInFinancingActivities>
<ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInFinancingActivities contextRef="ctx29" unitRef="vDKK" decimals="-3">2335000</ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInFinancingActivities>
<ifrs-dk:NameOfComponentOfCashFlowsFromUsedInFinancingActivities contextRef="ctx30" xml:lang="da">Sale of shares</ifrs-dk:NameOfComponentOfCashFlowsFromUsedInFinancingActivities>
<ifrs-dk:NameOfComponentOfCashFlowsFromUsedInFinancingActivities contextRef="ctx31" xml:lang="da">Transaction cost related to issuance of shares</ifrs-dk:NameOfComponentOfCashFlowsFromUsedInFinancingActivities>
<ifrs-dk:NameOfComponentOfCashFlowsFromUsedInFinancingActivities contextRef="ctx32" xml:lang="da">Transaction cost related to issuance of shares</ifrs-dk:NameOfComponentOfCashFlowsFromUsedInFinancingActivities>
<ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInFinancingActivities contextRef="ctx32" unitRef="vDKK" decimals="-3">-141000</ifrs-dk:AmountOfComponentOfCashFlowsFromUsedInFinancingActivities>
<ifrs-full:CashAndCashEquivalents contextRef="ctx33" unitRef="vDKK" decimals="-3">38918000</ifrs-full:CashAndCashEquivalents>
<ifrs-full:CashAndCashEquivalents contextRef="ctx34" unitRef="vDKK" decimals="-3">85692000</ifrs-full:CashAndCashEquivalents>
<cmn:NameAndSurnameOfMemberOfSupervisoryBoard contextRef="ctx35" xml:lang="da">Michael Hove</cmn:NameAndSurnameOfMemberOfSupervisoryBoard>
<cmn:TitleOfMemberOfSupervisoryBoard contextRef="ctx35" xml:lang="da">Chairman of the Board</cmn:TitleOfMemberOfSupervisoryBoard>
<cmn:NameAndSurnameOfMemberOfSupervisoryBoard contextRef="ctx36" xml:lang="da">Jakob Bendtsen</cmn:NameAndSurnameOfMemberOfSupervisoryBoard>
<cmn:NameAndSurnameOfMemberOfExecutiveBoard contextRef="ctx37" xml:lang="da">Jakob Bendtsen</cmn:NameAndSurnameOfMemberOfExecutiveBoard>
<cmn:TitleOfMemberOfExecutiveBoard contextRef="ctx37" xml:lang="da">Chief Executive Officer</cmn:TitleOfMemberOfExecutiveBoard>
<cmn:NameAndSurnameOfMemberOfExecutiveBoard contextRef="ctx38" xml:lang="da">Jakob Have</cmn:NameAndSurnameOfMemberOfExecutiveBoard>
<cmn:NameOfAuditFirm contextRef="ctx39" xml:lang="da">KPMG Statsautoriseret Revisionspartnerselskab</cmn:NameOfAuditFirm>
<cmn:IdentificationNumberCvrOfAuditFirm contextRef="ctx39">25578198</cmn:IdentificationNumberCvrOfAuditFirm>
<cmn:NameAndSurnameOfAuditor contextRef="ctx39" xml:lang="da">Sara Carstensen</cmn:NameAndSurnameOfAuditor>
<cmn:DescriptionOfAuditor contextRef="ctx39" xml:lang="da">State Authorised Public Accountant</cmn:DescriptionOfAuditor>
<cmn:IdentificationNumberOfAuditor contextRef="ctx39">mne34191</cmn:IdentificationNumberOfAuditor>
</xbrli:xbrl>